FindTrial
Sign In

Impact of teleconsultation on understanding, satisfaction and compliance of lung cancer patients

Impact of teleconsultation on understanding, satisfaction and compliance of lung cancer patients - Teleonco

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042232
Enrollment
100
Registered
2022-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C341- Malignant neoplasm of upper lobe,bronchus or lung

Interventions

Intervention1: Teleconsultation: Comparison between telemedicine OPD and physical OPD consultation for the follow-up of diagnosed lung cancer patients Intervention2: Telemedicine OPD: Teleconsultation

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients on oral targeted therapy Patients completed planned chemotherapy or immunotherapy

Exclusion criteria

Exclusion criteria: Patients requiring hospitalisation or urgent intervention Patients who are haemodynamically unstable Patients on chemotherapy or immunotherapy

Design outcomes

Primary

MeasureTime frame
To study patient understanding and satisfaction with teleconsultation in lung cancer patientsTimepoint: 4 weeks, 8 weeks, 12 weeks—

Secondary

MeasureTime frame
To determine out of pocket expenditure between two models of delivering consultation - physical vs teleconsultationTimepoint: 4 week , 8 week—

Countries

India

Contacts

Public ContactSandeep Kumar

PGIMER

bhadusandeep267@gmail.com08894625574

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026